Synthesis of Therapeutic Oligonucleotides

This book presents the latest knowledge on a broad range of topics relating to the synthesis of natural and artificial oligonucleotides with therapeutic potential. Nucleic acid-based therapeutics are attracting much attention, and numerous therapeutic oligonucleotides, such as antisense oligonucleot...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Obika, Satoshi (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Sekine, Mitsuo (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Singapore : Springer Singapore : Imprint: Springer, 2018.
Έκδοση:1st ed. 2018.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04741nam a2200493 4500
001 978-981-13-1912-9
003 DE-He213
005 20191025181023.0
007 cr nn 008mamaa
008 181208s2018 si | s |||| 0|eng d
020 |a 9789811319129  |9 978-981-13-1912-9 
024 7 |a 10.1007/978-981-13-1912-9  |2 doi 
040 |d GrThAP 
050 4 |a RS380 
050 4 |a RS190-210 
072 7 |a TDCW  |2 bicssc 
072 7 |a MED072000  |2 bisacsh 
072 7 |a TDC  |2 thema 
082 0 4 |a 615.19  |2 23 
245 1 0 |a Synthesis of Therapeutic Oligonucleotides  |h [electronic resource] /  |c edited by Satoshi Obika, Mitsuo Sekine. 
250 |a 1st ed. 2018. 
264 1 |a Singapore :  |b Springer Singapore :  |b Imprint: Springer,  |c 2018. 
300 |a VIII, 284 p. 208 illus., 35 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Part 1. Synthesis of Natural Oligonucleotides -- Chapter 1. Non-protected Synthesis of Oligonucleotides -- Chapter 2. Various Coupling Agents in the Phosphoramidite Method for Efficient Oligonucleotide Synthesis -- Chapter 3. Recent Development of Chemical Synthesis of RNA -- Chapter 4. RNA Synthesis Using the CEM Group -- Chapter 5. Liquid-Phase Synthesis of Oligonucleotides -- Chapter 6. Large-Scale Oligonucleotide Manufacturing -- Part 2: Synthesis and Properties of Artificial Oligonucleotides -- Chapter 1. Nucleosides and Oligonucleotides Incorporating 2-Thiothymine or 2-Thiouracil Derivatives as Modified Nucleobases -- Chapter 2. Site-Specific Modification of nucleobases in oligonucleotides -- Chapter 3. Four-Hydrogen-Bonding Base Pairs in Oligonucleotides: Design, Synthesis, and Properties -- Chapter 4. Photo-Cross-Linkable Artificial Nucleic Acid: Synthesis and Property of 3-Cyanovinylcarbazole-modified Nucleic Acids and Its Photo-induced Gene-Silencing Activity in Cells -- Chapter 5. Effects of 2´-O-Modifications on RNA Duplex Stability -- Chapter 6. 2',4'-Bridged Nucleic Acids Containing Plural Heteroatoms in the Bridge Moiety -- Chapter 7. Synthesis and Therapeutic Applications of Oligonucleotides Containing 2'-O,4'-C-Ethylene- and 3'-O,4'-C-Propylene-Bridged Nucleotides -- Chapter 8. RNA Bioisosters: Chemistry and Properties of 4'-ThioRNA and 4'-SelenoRNA -- Chapter 9. Development of Triplex Forming Oligonucleotide including Artificial Nucleoside Analogues for the Antigene Strategy -- Chapter 10. Chemical Synthesis of Boranophosphate Deoxyribonucleotides. 
520 |a This book presents the latest knowledge on a broad range of topics relating to the synthesis of natural and artificial oligonucleotides with therapeutic potential. Nucleic acid-based therapeutics are attracting much attention, and numerous therapeutic oligonucleotides, such as antisense oligonucleotides, siRNAs, splice-switching oligonucleotides, and nucleic acid aptamers, are being evaluated in clinical trials for the treatment of a variety of diseases. Synthesis of Therapeutic Oligonucleotides covers a broad range of topics in the field that are of high relevance to researchers, including the synthesis of natural and chemically modified oligonucleotides, the development of novel nucleic acid analogs, industrial scale synthesis and purification of oligonucleotides, and important aspects of chemistry, manufacturing, and controls (CMC). The aim is to provide new insights and inspire fresh ideas in nucleic acid chemistry that may ultimately lead to novel concepts and techniques and the discovery of more effective nucleic acid drugs. The book will be of high value for both established researchers in the field and students intending to specialize in nucleic acid chemistry research. 
650 0 |a Pharmaceutical technology. 
650 0 |a Medicinal chemistry. 
650 0 |a Molecular biology. 
650 1 4 |a Pharmaceutical Sciences/Technology.  |0 http://scigraph.springernature.com/things/product-market-codes/B21010 
650 2 4 |a Medicinal Chemistry.  |0 http://scigraph.springernature.com/things/product-market-codes/C28000 
650 2 4 |a Molecular Medicine.  |0 http://scigraph.springernature.com/things/product-market-codes/B1700X 
700 1 |a Obika, Satoshi.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Sekine, Mitsuo.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9789811319112 
776 0 8 |i Printed edition:  |z 9789811319136 
856 4 0 |u https://doi.org/10.1007/978-981-13-1912-9  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)